Deputy Director of Administration, Department of Endocrinology, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Chief Physician, Doctoral Supervisor, M.D. Specializes in the clinical diagnosis and treatment of polycystic ovary syndrome and metabolic-immune-related endocrine diseases. Senior Research Scholar at Massachusetts General Hospital, Harvard Medical School, USA, and Visiting Scholar at the Reproductive Endocrinology Center, University of Virginia, USA. Has presided over 12 national and municipal-level projects, published more than 40 SCI papers and more than 20 Chinese core journal papers. Has long been engaged in clinical, research, and teaching work in endocrinology. Specializes in the diagnosis and treatment of endocrine diseases related to obesity and insulin resistance, especially having devoted more than 20 years to the subspecialty of polycystic ovary syndrome (PCOS). Took the lead in exploring a treatment model combining genetic background screening of insulin resistance in PCOS with precision therapy, improved the clinical management pathway and follow-up system for PCOS, and integrated multidisciplinary comprehensive diagnosis and treatment to form a precision intervention model achieving different goals for different PCOS phenotypes. As the first author, drafted and published the first "Endocrine Expert Consensus on the Diagnosis and Treatment of Polycystic Ovary Syndrome" in the field of endocrinology and metabolism, and served as editor-in-chief and published the monograph "Polycystic Ovary Syndrome and Endocrine Infertility." From 2011 to 2021, ranked second in the Fudan University expert rankings in the field of PCOS. Also collaborated with the Department of General Surgery and the Department of Reproductive Medicine to take the lead in conducting research in the PCOS population on the effects of preconception metabolic intervention (pharmacological and metabolic surgery) on pregnancy complications and offspring live birth rate, proposed the important role of preconception metabolic intervention in reducing transgenerational inheritance of PCOS, constructed a long-term follow-up cohort, and explored strategies for assisted reproduction in PCOS patients and the prevention of metabolic-related diseases in offspring. Conducts research on the etiological mechanisms of PCOS, deeply explores the mechanisms by which the brain-gut-ovary axis participates in the disease from the periphery to the center, and proposes a whole-life-cycle management strategy for PCOS patients, safeguarding the lifelong health of women with PCOS.